
    
      The scientific purpose of this study is to obtain data on the use of paricalcitol iv in
      real-life clinical practice and the effect it has on participant health-related QoL. In this
      study, paricalcitol iv will be prescribed on an on-label basis in an everyday setting. The
      RAND 36-Item Health Survey results will be collected for a 6-month period (every 3 months) in
      order to assess the effect of paricalcitol iv on participant health-related QoL.
    
  